Shock Wave Versus Iontophoresis in Treatment of Subjects With Knee Osteoarthritis (Shockwave)

March 5, 2023 updated by: Shimaa Taha Abu El Kasem, Cairo University

Effect of Extra Corporeal Shock Wave Versus Dexamethasone Iontophoresis in Treatment of Knee Osteoarthritis

Both extra corporeal shock wave and dexamethasone iontophoresisare effective in treatment of knee osteoarthritis but which one is more effective is not clear yet . so the purpose of this study was to investigate and compare between the effect of shock wave and iontophoresis in treatment of knee osteoarthritis . it was hypothesized that there will be no difference between the effect of shock wave and iontophoresis on treatment of knee osteoarthritis.

Study Overview

Detailed Description

60 subjects with grade II knee osteoarthritis will be recruited from outpatient clinic of faculty of physical therapy and then they will be assigned randomly by sealed envelope into three groups ;group A (shock wave group) will received radial extracorporeal shock wave ,group B (Iontophoresis group ) will receive deaxamthasone iontophoresis and group c (control group) will receive traditional tratment ( stregnthening exerciseces) all treatment will be once session per week for four weeks .pain intensity ,knee ROM and knee injury and osteoarthritis outcome score physical function short (KOOS-PS).

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Giza, Egypt, 002
        • faculty of physical therapy ,Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Symptomatic knee OA for at least 3 months according to clinical criteria of American College of Rheumatology
  2. Radiologic findings had to be compatible with knee OA, with kelgren and Lawrence (K-L) grade 2 in a simple X ray .
  3. Tenderness on medial tibial plateau
  4. Intensity of pain: visual analogue scale equal to 5 or greater
  5. Failure of two or more types of previous conservative treatment (medication, anti-inflammatory drugs, physical therapy, stretching, acupuncture, orthotics and others)

Exclusion Criteria:

  1. Neuorological and vestibular system disorder, systematic inflammatory disease, steroid injections in the last six months
  2. Any contraindication to magnetic resonance imaging or radiography, or trauma history on knee
  3. history of previous knee surgery -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Shock wave(A)
subjects will recive radial extracorporeal shock wave (2000 shock/session, 10Hz and EFD 0.178 mJ/mm²) on knee joints once per week for four weeks in addition to strengthening exercise
Radial shock wave device, Swiss DolorClast (EMS Electro Medical Systems, Nyon, Switzerland)
strengthening exercise
Experimental: Iontophoresis (B)
subjects will recive dexamethasone iontophoresis on knee joints once per week for four weeks in addition to strengthening exercise
strengthening exercise
Iontophoretic drug delivery system (phoresors II auto model PM850 IOMED):
Other: Control (C)
stregnthening exercise;straight leg raising exercisein which the patients were positioned in the crook lying position with the unexercised limb was the flexed one then the patients were asked to contract the quadriceps muscle and elevate the limb to 45º and hold for 6 seconds, slowly lower the limb and then relax for 6 seconds, three sets of 10 repetitions were don ,Isometric quadriceps contraction (quadriceps drill) in full knee extension maintained for 5 seconds, followed by a 5-second rest; the exercise was performed for 20 repetitions per session .treatment once per week for four weeks
strengthening exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
visual analogue scale (VAS)
Time Frame: change from baseline to immediately pre treatment and from pre treatment to immediately post treatment
pain intensity will be assessed by using visual analogue scale
change from baseline to immediately pre treatment and from pre treatment to immediately post treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
knee range of motion (ROM)
Time Frame: change from baseline to immediately pre treatment and from pre treatment to immediately post treatment
electronic geniometer
change from baseline to immediately pre treatment and from pre treatment to immediately post treatment
knee injury and osteoarthritis outcome score physical function short (KOOS-PS)
Time Frame: change from baseline to immediately pre treatment and from pre treatment to immediately post treatment
knee function by using KOOS-PS questionnaire
change from baseline to immediately pre treatment and from pre treatment to immediately post treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2021

Primary Completion (Actual)

November 1, 2022

Study Completion (Actual)

January 15, 2023

Study Registration Dates

First Submitted

January 16, 2021

First Submitted That Met QC Criteria

January 28, 2021

First Posted (Actual)

January 29, 2021

Study Record Updates

Last Update Posted (Estimate)

March 7, 2023

Last Update Submitted That Met QC Criteria

March 5, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • REC/012/002633

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on radial extracorporeal shock wave

Subscribe